A medication review is a conversation with a pharmacist or another qualified healthcare professional about the medicines a person takes, what each is for, and whether the treatment is working safely and practically. It includes prescription medicines, over-the-counter products, vitamins and supplements, along with questions about side effects, cost and how the person actually takes them.
The useful outcome is an agreed next step for each concern: an explanation, a corrected medication list, a question for the prescriber or a follow-up plan. For a pharmacy offering the service, explaining those outcomes makes the appointment more concrete than asking a patient to book an “MTM.”
What happens during a medication review?
The pharmacist asks about the patient's priorities and compares the available records with what the patient reports taking. A dispensing history shows what was supplied; it may miss a supplement bought elsewhere, a medicine stopped after discharge or a dose the patient takes differently from the label.
The discussion then considers why each medicine is used, whether it is helping, possible unwanted effects or interactions, and practical difficulties such as cost or an awkward schedule. These are parts of the Joint Commission of Pharmacy Practitioners' patient care process. The pharmacist agrees on a plan with the patient and arranges follow-up for concerns that need more work.
A review can happen in person or through an appropriate remote service. Ask the provider how long to reserve and what format it offers. For example, Humana describes its CMR consultations as roughly 10 to 30 minutes; that is a program example, not a duration every pharmacy must use.
Medication review, reconciliation, CMR and MTM
Medication reconciliation focuses on establishing an accurate medication list and resolving discrepancies between sources, particularly when care changes settings. AHRQ describes it as comparing the current regimen with admission, transfer or discharge orders and resolving differences with the prescriber. That work may reveal an issue for a broader medication review to assess.
Medication therapy management, or MTM, is a set of services intended to help people use medicines effectively and safely. A comprehensive medication review, or CMR, is a broad review within that service. In Medicare Part D MTM, it includes a real-time discussion and a written summary in CMS's Standardized Format. A targeted medication review, or TMR, addresses specific medication-related concerns within the program. CMS describes the Part D program requirements.
“Medication review” is also used outside Medicare's program. The appointment name alone doesn't tell you its scope, payment arrangement or deliverables. Ask whether the booking is a plan-sponsored CMR, a focused consultation or another pharmacy service.
What should the patient bring?
Bring the current medication list and, for an in-person review, the medicine containers or organizers the pharmacy requests. For a telephone or video appointment, have them within reach. Include products from other pharmacies and medicines used only occasionally, as well as inhalers, injections, creams, vitamins and supplements.
Tell the pharmacist what you actually take, including anything you have stopped or changed. Note the questions you want answered: an unwanted effect, a medicine you can't afford, a confusing instruction or difficulty using a device. The FDA's pharmacist-conversation guide explains why those details matter.
Recent discharge instructions or a changed prescription can help explain differences in the record. A caregiver who helps manage the medicines may also have useful information; confirm participation arrangements when scheduling. A personal medication record helps collect the list.
An example: the record is accurate, but the routine isn't working
In this hypothetical review, a patient says they often miss a lunchtime dose because they can't carry out the instructions during their work shift. The medicine and prescribed directions are correctly recorded. Simply confirming the list would leave the practical problem unresolved.
The pharmacist asks what happens on workdays, assesses the concern and discusses options within their scope. If a change needs the prescriber's decision, the pharmacist contacts the prescriber and tells the patient what remains pending. The patient shouldn't leave believing that a proposed schedule is already an approved change.
Once the plan is confirmed, the pharmacist explains the instructions and follows up on whether the patient can use them. The clinical record can distinguish the problem, proposed action and confirmed outcome; our pharmacy care-plan example covers that documentation in more detail.
Who can request a review, and what does it cost?
A patient can ask a pharmacist about a review when medicines change, instructions conflict, side effects are a concern or the routine is difficult to manage. The pharmacy can explain which service fits and whether a scheduled visit or another clinical response is appropriate.
For people who qualify for a Medicare drug plan's MTM program, Medicare says these services are available at no cost to the patient. Contact the plan to confirm eligibility and arrange the service. That no-cost rule should not be extended to every privately arranged medication consultation.
Part D plans enroll qualifying members using an opt-out approach. An enrolled member can decline an individual CMR without leaving the MTM program, as CMS explains in its program guidance. Blue Shield of California's 2026 program explains how eligible members can opt out and describes both telephone and in-person reviews. A pharmacy invitation should explain the service without telling the patient that insurance requires them to complete the CMR.
If an invitation comes from an unfamiliar caller, verify the service through the plan's published contact information before sharing personal details. Humana notes that partner organizations may contact members on its behalf, so an unfamiliar organization is a reason to verify the invitation, not automatically dismiss it.
What should happen after the appointment?
The patient should understand which instructions are confirmed, which questions still need an answer and how follow-up will happen. Medicare Part D CMR materials include a written summary with a medication list and recommended actions. Keep that patient-facing information distinct from the pharmacist's clinical notes.
For a plan-assigned CMR, use the program's designated workflow and required patient materials. When developing the pharmacy's own service, decide how the patient receives the agreed plan and how the pharmacist tracks unfinished work. A completed appointment can still leave a prescriber response pending; confirm that response and communicate the resulting plan before treating the concern as resolved.
